• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4624956)   Today's Articles (168)   Subscriber (49456)
For: Petzke F, Enax-Krumova EK, Häuser W. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies]. Schmerz 2017;30:62-88. [PMID: 26830780 DOI: 10.1007/s00482-015-0089-y] [Citation(s) in RCA: 53] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Number Cited by Other Article(s)
51
Pisanti S, Malfitano AM, Ciaglia E, Lamberti A, Ranieri R, Cuomo G, Abate M, Faggiana G, Proto MC, Fiore D, Laezza C, Bifulco M. Cannabidiol: State of the art and new challenges for therapeutic applications. Pharmacol Ther 2017;175:133-150. [PMID: 28232276 DOI: 10.1016/j.pharmthera.2017.02.041] [Citation(s) in RCA: 354] [Impact Index Per Article: 50.6] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
52
Radbruch L, Schäfer M. [Cannabis as a therapeutic agent: Focal topic]. Schmerz 2016;30:1-2. [PMID: 26809973 DOI: 10.1007/s00482-015-0086-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
53
Ablin J, Ste-Marie PA, Schäfer M, Häuser W, Fitzcharles MA. Medical use of cannabis products. Schmerz 2016;30:3-13. [DOI: 10.1007/s00482-015-0083-4] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
PrevPage 2 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA